Acura Pharmaceuticals Inc (ACUR.OQ)

ACUR.OQ on NASDAQ Stock Exchange Capital Market

2.01USD
1 Aug 2013
Price Change (% chg)

$-0.03 (-1.47%)
Prev Close
$2.04
Open
$1.99
Day's High
$2.01
Day's Low
$1.95
Volume
17,923
Avg. Vol
92,919
52-wk High
$4.49
52-wk Low
$1.06

ACUR.OQ

Chart for ACUR.OQ

About

Acura Pharmaceuticals, Inc., is a specialty pharmaceutical company engaged in the research, development and commercialization of products focused on addressing medication abuse and misuse, utilizing its Aversion and Impede Technologies. Aversion is a mixture of inactive ingredients incorporated into pharmaceutical tablets and... (more)

Overall

Beta: 0.80
Market Cap (Mil.): $94.61
Shares Outstanding (Mil.): 46.38
Dividend: --
Yield (%): --

Financials

  ACUR.OQ Industry Sector
P/E (TTM): -- 47.13 37.76
EPS (TTM): -0.24 -- --
ROI: -40.70 -2.58 18.76
ROE: -40.70 -2.66 19.59
Search Stocks

Competitors

  Price Change
Pain Therapeutics, Inc. (PTIE.OQ) $2.46 +0.04
Pfizer Inc. (PFE.N) $29.29 +0.06
Grifols SA (GRLS.MC) €32.62 +0.92
Grifols SA (GRLSbn.MC) €24.52 +0.43
Onyx Pharmaceuticals, Inc. (ONXX.OQ) $132.95 +1.65
AstraZeneca plc (AZN.L) 3,322.50p -12.50
Bayer AG (BAYGn.DE) €89.67 +2.32
Bayer AG (BAYE.F) -- --

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Wright Reports
$472.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks